From July 13, 2023 to August 31, 2023, the company has repurchased 277,400 shares, representing 0.36% for ¥1,333.6 million. With this, the company has completed the repurchase of 277,400 shares, representing 0.36% for ¥1,333.6 million under the buyback announced on July 13, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,779 JPY | +1.86% | +1.61% | -12.34% |
Apr. 11 | Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024 | MT |
Jan. 12 | Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.34% | 1.82B | |
+25.83% | 661B | |
+26.50% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.87% | 231B | |
+5.28% | 200B | |
-8.79% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 4530 Stock
- News Hisamitsu Pharmaceutical Co., Inc.
- Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.